Injection Pen Market Research Report Information By Type (Disposable Injection Pens), By Product (Insulin Pens and Needles), By Therpy (Diabetes), By Distribution Channel (Hospital Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Global Injection Pen Market Overview:

Injection Pen Market Size was valued at USD 43.2 billion in 2021 and is projected to grow from USD 46.18 Billion in 2022 to USD 73.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.90% during the forecast period (2022 - 2030).The need for injectable pen technologies has increased to properly address the rising patient pool and promote treatment adherence are the key market drivers enhancing the market growth.

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Injection Pen Market Trends

• Growing Prevalence of patients and promote treatment to boost market growth

Injection Pen Market Segment Insights

Injection Pen Type Insights

The  injection pen market segmentation, based on type, disposable injection pens. The disposable injection pen segment held the majority share in 2021 in respect to the  injection pen market revenue. This is explained by the disposable injection pens' high level of affordability and safety. Due to the reusability of the injections, the disposable injection pens enhance safety against blood-borne infections and can only be used once. The disposable injection pen market has been expanding over the past few years because to factors such ease of accessibility, rising consumer awareness, rising healthcare costs, and an increase in the prevalence of diseases associated to insulin.

Injection Pen Product Insights

The  injection pen market segmentation, based on product, includes insulin pens and pen needles. The insulin pen segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. This is due to the increasing diabetes patients. As per the International diabetes federation, the diabetic population is expected to reach at 643 million by 2030 ly.

For Instance: Reusable smart insulin pens, are now readily accessible and come with an intuitive smartphone app that can help diabetics better control their insulin dosage. Additionally, these are frequently more affordable, simpler to use, and offer a number of advantages and enhancements for patients who rely on insulin to treat their diabetes; as a result, demand for such innovative technologies is only increasing, which is fueling market revenue growth.

Injection Pen Therapy Insights

The  injection pen market data has been bifurcated by therapy in diabetes. The diabetes segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2022-2030. The increasing prevalence of diabetes, rising awareness of insulin pens among diabetic patients, the growing availability of insulin pens, and the increasing elderly population are the major contributors in the market growth.

The World Health Organization claims that diabetes is a significant contributor to kidney failure, blindness, and stroke. Additionally, cardiovascular illnesses are the main cause of death worldwide, accounting for 32% of all fatalities. Therefore, it is anticipated that the  market for injectable pens will experience growth due to the rising prevalence of different chronic and non-communicable diseases among the population.

Injection Pen Distribution Channel Insights

Based on Distribution Channel, the  injection pen industry has been segmented into hospital and pharmacies. Hospitals held the largest segment share in 2021, owing to the rapid adoption of injection pen. Moreover, increasing government initiatives to improve the healthcare infrastructure, and the growing number of diabetes patients is expected to boost the market during the assessed timeline. Improved consumer spending on healthcare, rising disposable income, increased consumer knowledge of the use of injection pens are the main drivers of this market's expansion.

Injection Pen Regional Insights

By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Injection Pen market accounted for USD 18.79 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing diabetic patients and rising elderly population across the region.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2:  INJECTION PEN MARKET SHARE BY REGION 2021 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe injection pen market accounts for the second-largest market share due to the availability of cutting-edge treatment facilities, government backing for the growth of the healthcare industry, an ageing population, and an increase in incidence of diabetic disease, cancer. Further, the Germany injection pen market held the largest market share, and the UK injection pen market was the fastest growing market in the European region

The Asia-Pacific injection pen Market is expected to grow at the fastest CAGR from 2022 to 2030. Increasing rates of chronic diseases due to the unhealthy food, physical inactivity, and the increasing consumption of tobacco and alcohol in youth. Moreover, China injection pen market held the largest market share, and the India injection pen market was the fastest growing market in the Asia-Pacific region.

Injection Pen Key Market Players & Competitive Insights

Major market players are spending a lot of money on R&D to increase their product lines, which will help the Injection Pen market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the injection pen industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  injection pen industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, injection pen industry has provided medicine with some of the most significant benefits. The injection pen market major player such as Novo Nordisk, Eli Lilly, Sanofi, Merck, Ypsomed, AstraZeneca, Hoffman-La Roche, Becton Dickinson and Company, Owen Mumford, Novartis and others are working to expand the market demand by investing in research and development activities.

Sanofi, is a cutting-edge healthcare organisation with a single goal: to use science's wonders to enhance people's lives. Company’s team works to change the way medication is delivered to patients by making the seemingly impossible feasible. It protect millions of people with potentially life-saving vaccines and treatments, and we give them inexpensive access to our medications in some of the world's poorest nations.

For Instance: April 2020, the FDA approved Sanofi (Francenovel )'s Dupixent prefilled pen for use in the management of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis. The pen can be used at home for administration.

Also, In June of this year, Sanofi (France), the manufacturer of the Toujeo SoloStar Pens, received approval in Europe.

Merck is a major provider of solutions and services for the study, creation, and distribution of pharmaceutical and biotechnology drug therapies for the worldwide life science market. Together with its coworkers, clients, and stakeholders, company use science to improve life and health. Researchers must have access to cutting-edge equipment, services, and knowledge in order to conduct tests and design new products before they can create scientific breakthroughs.

With best-in-class solutions for pharmaceutical development and manufacture, a fully integrated service organisation to support CDMO and contract testing across conventional and cutting-edge modalities, and one of the broadest portfolios in the sector for scientists, we lead the market.

For Instance: January 2019, Merck KGaG released Pergoveris in as an injectable gonadotropin pen for reproductive therapy (Germany).

Key Companies in the injection pen market includes

• Novo Nordisk


• Eli Lilly


• Sanofi


• Merck


• Ypsomed


• AstraZeneca


• Hoffman-La Roche


• Becton Dickinson and company


• Owen Mumford


• Novartis

Injection Pen Industry Developments

October 2017: Eli Lilly launched Humalog Junior KwikPen for the U.S. diabetic patients.

2019: Becton, Dickinson and company (BD) have introduced the BD Stevia, a thorough two-step disposable auto-injector. The parental drug association in 2019 universe of injection devices and pre-filled syringes conference saw the unveiling of this platform device, which is a combination of pre-fillable syringe and insulin auto-injector pen in one integrated system.

As per TEVA PHARMACEUTICALS USA,INC, the AJOVY auto-injector has been commercial launched in United States. This kind of injection pen is designed to treat migraines in adults as per preventative measure.

Injection Pen Market Segmentation

Injection Pen Type Outlook

• Disposable Injection Pens

Injection Pen Product Outlook

• Insulin Pens


• Pen Nedles

Injection Pen Therapy Outlook

• Diabetes

Injection Pen Distribution Channel Outlook

• Hospital Pharmacies

Injection Pen Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  


• Latin America